NL192664C - Werkwijze voor het bereiden van gevriesdroogd preparaat van natrium-piperacilline. - Google Patents

Werkwijze voor het bereiden van gevriesdroogd preparaat van natrium-piperacilline. Download PDF

Info

Publication number
NL192664C
NL192664C NL8201251A NL8201251A NL192664C NL 192664 C NL192664 C NL 192664C NL 8201251 A NL8201251 A NL 8201251A NL 8201251 A NL8201251 A NL 8201251A NL 192664 C NL192664 C NL 192664C
Authority
NL
Netherlands
Prior art keywords
sodium
solution
piperacillin
water
freeze
Prior art date
Application number
NL8201251A
Other languages
English (en)
Dutch (nl)
Other versions
NL192664B (nl
NL8201251A (nl
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192664(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NL8201251A publication Critical patent/NL8201251A/nl
Publication of NL192664B publication Critical patent/NL192664B/xx
Application granted granted Critical
Publication of NL192664C publication Critical patent/NL192664C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8201251A 1981-03-26 1982-03-25 Werkwijze voor het bereiden van gevriesdroogd preparaat van natrium-piperacilline. NL192664C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26
US24758681 1981-03-26

Publications (3)

Publication Number Publication Date
NL8201251A NL8201251A (nl) 1982-10-18
NL192664B NL192664B (nl) 1997-08-01
NL192664C true NL192664C (nl) 1997-12-02

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8201251A NL192664C (nl) 1981-03-26 1982-03-25 Werkwijze voor het bereiden van gevriesdroogd preparaat van natrium-piperacilline.

Country Status (23)

Country Link
JP (1) JPS57159708A (de)
AT (1) AT395533B (de)
AU (1) AU549784B2 (de)
BE (1) BE892541A (de)
CA (1) CA1209477A (de)
CH (1) CH652306A5 (de)
DE (2) DE3208505A1 (de)
DK (1) DK157976C (de)
ES (1) ES509234A0 (de)
FR (1) FR2502624B1 (de)
GB (1) GB2095551B (de)
GR (1) GR78386B (de)
HK (1) HK39189A (de)
HU (1) HU186489B (de)
IE (1) IE52936B1 (de)
IL (1) IL64924A (de)
IT (1) IT1147916B (de)
LU (1) LU84031A1 (de)
NL (1) NL192664C (de)
NZ (1) NZ199632A (de)
PL (1) PL130564B1 (de)
SE (1) SE453153B (de)
ZA (1) ZA82605B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
BRPI0415531B8 (pt) 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
AR067747A1 (es) 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd Metodos para producir suspension de aripiprazol y formulacion liofilizada
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
NL192664B (nl) 1997-08-01
ES8302455A1 (es) 1982-12-16
SE8200591L (sv) 1982-09-27
BE892541A (fr) 1982-09-20
CH652306A5 (de) 1985-11-15
AT395533B (de) 1993-01-25
DE3208505A1 (de) 1982-10-21
NL8201251A (nl) 1982-10-18
GB2095551B (en) 1984-10-03
SE453153B (sv) 1988-01-18
IT8248034A0 (it) 1982-03-19
NZ199632A (en) 1985-07-12
DE19375106I2 (de) 2006-02-16
FR2502624A1 (fr) 1982-10-01
IT1147916B (it) 1986-11-26
DK48382A (da) 1982-09-27
HU186489B (en) 1985-08-28
IE52936B1 (en) 1988-04-13
FR2502624B1 (fr) 1985-10-25
GB2095551A (en) 1982-10-06
AU549784B2 (en) 1986-02-13
AU7986582A (en) 1982-09-30
JPH0219804B2 (de) 1990-05-07
DK157976C (da) 1990-08-27
PL235509A1 (de) 1982-12-20
JPS57159708A (en) 1982-10-01
CA1209477A (en) 1986-08-12
IE820703L (en) 1982-09-26
IL64924A0 (en) 1982-04-30
DK157976B (da) 1990-03-12
DE3208505C2 (de) 1991-11-28
ZA82605B (en) 1982-12-29
IL64924A (en) 1985-07-31
ATA92982A (de) 1992-06-15
GR78386B (de) 1984-09-26
PL130564B1 (en) 1984-08-31
LU84031A1 (de) 1982-07-08
HK39189A (en) 1989-05-19
ES509234A0 (es) 1982-12-16

Similar Documents

Publication Publication Date Title
AU2016326749B2 (en) Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
CA2687246A1 (en) High temperature stable peptide formulation
JP2002363097A (ja) 安定化された凍結乾燥型医薬組成物
CN105796589A (zh) 用于治疗关节的组合物和方法
US4477452A (en) Composition of matter comprising a lyophilized preparation of a penicillin derivative
NL192664C (nl) Werkwijze voor het bereiden van gevriesdroogd preparaat van natrium-piperacilline.
DE69928500T2 (de) Pharmazeutische zusammensetzung enthaltend den phospholipase inhibitor natrium-[[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1 h-indol-4-yl]oxy]acetat
US3269905A (en) Dry stratiform products and methods of producing same
US4534977A (en) Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
JPS63166832A (ja) 鼻用溶液
ES2215856T3 (es) Solucion de sal monosodica tetrahidrato de n-(o-(p-pivaloiloxibenceno-sulfonilamino)benzoil)glicina y medicamento que contiene esta solucion.
JPS635028A (ja) 凍結乾燥医薬組成物
KR20040017330A (ko) 2-메틸-티에노-벤조디아제핀 동결건조 제제
US11590205B2 (en) Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
US2487975A (en) Therapeutic preparations for intramuscular or subcutaneous injection and methods of making the same
Van Hoogdalem et al. 3‐Amino‐1‐hydroxypropylidene‐1, 1‐diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats
JP7423028B2 (ja) ボルテゾミブを含有する凍結乾燥医薬組成物
JPS61171421A (ja) 安定なプロスタグランジンｅ類製剤の製造方法
CA2994748C (en) Pharmaceutical composition comprising sumatripan for treating migraine
RU2680804C1 (ru) Стабильное средство лечения болезней суставов
CA1062157A (en) Stable injection solutions
JP3956654B2 (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物含有溶液および製剤
KR860000512B1 (ko) 페니실린 유도체의 동결 건조물로 된 주사용량 단위물 제조방법
CN1074278C (zh) 前列腺素e1无菌冻干粉针剂生产工艺
TW202434258A (zh) 溶液、凍乾製劑、凍乾製劑單位包裝、注射液及注射液配製方法

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020325

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20020325